You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

22-223

Showing 26 - 50 of 3,663
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • La Jolla, California
  • +21 more
Dec 2, 2022

Prostate Cancer Trial in Ireland (Radium-223 and enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Radium-223 and enzalutamide
  • Cork, Ireland
  • +6 more
Feb 18, 2021

Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)

Recruiting
  • Prostate Cancer
  • Docetaxel 75 mg/m2
  • +2 more
  • Gilbert, Arizona
  • +52 more
Feb 2, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • Daphne, Alabama
  • +241 more
Dec 23, 2022

Radium-223 is and How Well it Works in Chinese Advanced Prostate

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, China
    Many locations
Aug 10, 2022

Learn More About How Radium-223 Affects Quality of Life of

Recruiting
  • Prostate Cancer
  • Radium-223-dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Colombia
    Many Locations
Jan 19, 2023

Metastatic Castrate Resistant Prostate Cancer (mCRPC) Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), NAH

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer (mCRPC)
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • NAH therapy
  • Castle Hill, New South Wales, Australia
  • +156 more
Jan 13, 2023

Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

Recruiting
  • Prostate Adenocarcinoma
  • Leuprolide Acetate
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Santa Barbara, California
  • +22 more
Jan 25, 2023

Prostate Cancer Trial in United States (Radium dichloride, PET Scan)

Recruiting
  • Prostate Cancer
  • Radium dichloride
  • PET Scan
  • Aurora, Colorado
  • +8 more
Sep 15, 2022

Tumor Metastasis / Bone and Bones Trial in Worldwide (Data Collection)

Recruiting
  • Neoplasm Metastasis / Bone and Bones
  • Data Collection
  • Anchorage, Alaska
  • +156 more
Aug 22, 2022

MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy

Not yet recruiting
  • Drug Resistant Epilepsy
  • MiRNA223 and High mobility group box1(HMGB1)
  • (no location specified)
Oct 16, 2022

Small Cell Lung Cancer, SCLC Trial in Worldwide (Pembrolizumab, Normal saline solution, Carboplatin)

Completed
Has Results
  • Small Cell Lung Cancer (SCLC)
  • Pembrolizumab
  • +4 more
  • Miami, Florida
  • +147 more
Sep 2, 2022

Liver Cirrhosis, Liver Trial (Sequential Adult Left Lateral Liver Transplantation)

Not yet recruiting
  • Liver Cirrhosis
  • Liver
  • Sequential Adult Left Lateral Liver Transplantation
  • (no location specified)
Nov 22, 2023

Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)

Active, not recruiting
Has Results
  • Breast Neoplasms
  • Fayetteville, Arkansas
  • +141 more
Nov 15, 2022

Non-study Population of Symptomatic mCRPC Patients Treated With

Active, not recruiting
  • Prostate Cancer Metastatic
  • Bone Metastases
  • Blood tests
  • Amsterdam, Netherlands
  • +1 more
Apr 20, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

Children With Attention Deficit Hyperactivity Disorder

Not yet recruiting
  • Attention Deficit Hyperactivity Disorder
    • Antalya, Turkey
      Akdeniz University
    Jun 1, 2023

    Prostate Cancer Trial in Baltimore (Radium-223, stereotactic ablative radiotherapy (SABR))

    Recruiting
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins
    May 25, 2022

    Polycystic Ovary Syndrome, Metformin Trial in Dhaka (Metformin Hydrochloride)

    Not yet recruiting
    • Polycystic Ovary Syndrome
    • Metformin
    • Metformin Hydrochloride
    • Dhaka, Bangladesh
      Department of Endocrinology, Bangabandhu Sheikh Mujib Medical Un
    Jan 9, 2023

    Axial Spondyloarthritis Trial in Worldwide (Ixekizumab, Placebo)

    Completed
    Has Results
    • Axial Spondyloarthritis
    • Phoenix, Arizona
    • +126 more
    May 12, 2022

    Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)

    Completed
    • Periodontitis
    • Diabetes Mellitus, Type 2
    • Non-Surgical Periodontal Treatment
    • Istanbul, Turkey
      Marmara University
    Nov 11, 2023

    Rebound Pain Following Surgery With Regional Anesthesia Block

    Recruiting
    • Regional Anesthesia Morbidity
    • Pain, Postoperative
    • Numerical Pain Scales
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    Jan 10, 2023